Skip to main content
Elos Medtech logo

Elos Medtech — Investor Relations & Filings

Ticker · ELOS ISIN · SE0000120776 LEI · 529900I5MSNU451FL670 ST Manufacturing
Open in API
Filings indexed 331 across all filing types
Latest filing 2020-11-02 Capital/Financing Update
Country SE Sweden
Listing ST ELOS

About Elos Medtech

http://elosmedtech.com

Elos Medtech is a contract development and manufacturing organization (CDMO) specializing in the medical device sector. The company partners with medical technology firms, providing comprehensive services that span the entire product lifecycle, from research and development to manufacturing and commercialization. Its core focus areas include dental, orthopedics, and advanced surgical products. Elos Medtech offers a range of capabilities, including precision manufacturing, polymer injection molding, process optimization, packaging, and regulatory support. The company operates through specialized business units that collaborate to provide clients with tailored solutions, aiming to streamline operations, reduce complexity, and accelerate innovation in the medical device field.

Recent filings

Filing Released Lang Actions
Elos Medtech investing to meet increased demand in robotic surgery
Capital/Financing Update Classification · 99% confidence The document announces a strategic investment decision by the Board of Directors of Elos Medtech to meet increased demand in robotic surgery, involving capital expenditure (SEK 70 million over three years) and expected sales growth. This content relates to financing activities, capital structure changes, and significant business strategy updates that impact the company's financial outlook. It is not a full annual report (10-K), an earnings release (ER), or a quarterly report (IR). Since it details a significant financing/investment decision impacting capital structure and future operations, the most appropriate category is Capital/Financing Update (CAP). It is too specific for a general Regulatory Filing (RNS) and does not fit the definitions for M&A (TAR), Director's Dealing (DIRS), or Dividend (DIV).
2020-11-02 English
Interim / Quarterly Report 2020
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Q3 2020 DELÅRSRAPPORT' (Interim Report) and contains comprehensive financial statements, key performance indicators (KPIs), management commentary, and operational updates for the third quarter of 2020. It provides detailed financial data rather than just an announcement or summary, fitting the definition of an Interim/Quarterly Report (IR). Q3 2020
2020-10-20 Swedish
Interim / Quarterly Report 2020
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Q3 2020 INTERIM REPORT' and contains comprehensive financial statements, key performance indicators, and management commentary for the third quarter and the first nine months of 2020. It provides actual financial data rather than just an announcement or certification, fitting the definition of an Interim/Quarterly Report. Q3 2020
2020-10-20 English
Elos Medtech valberedning utsedd inför årsstämman 2021
AGM Information Classification · 98% confidence The document is titled "Elos Medtech valberedning utsedd inför årsstämman 2021" (Elos Medtech Nomination Committee appointed ahead of the 2021 Annual General Meeting). It details the composition of the Nomination Committee (Valberedningen), lists the appointed members representing major shareholders, and outlines the proposals the committee will present to the upcoming Annual General Meeting (AGM) on May 3, 2021. This content directly relates to the preparation and governance structure surrounding the AGM, specifically concerning the election of directors and setting remuneration, which falls under the scope of AGM preparation materials. While it is not the AGM presentation itself (AGM-R) or the proxy statement (DEF 14A/PSI), the focus on the Nomination Committee's composition and mandate strongly aligns with governance topics often associated with AGM preparation. However, given the specific definitions, the content is most closely related to the governance structure leading up to the meeting, but since it is about the *appointment* of the committee that prepares proposals for the AGM, and not the AGM itself or the proxy materials soliciting votes, it is best classified as Governance Information (CGR) or potentially AGM Information (AGM-R). Since the core subject is the establishment and composition of the body responsible for proposing board members and remuneration for the AGM, CGR (Governance Information) is a strong fit, as it details internal rules/structure related to board appointments. However, because the entire context is explicitly tied to the upcoming 'årsstämman' (AGM) and the committee's role is defined by the previous AGM's decision, AGM-R is also plausible if interpreted broadly as AGM-related documentation. Given the explicit mention of the AGM date and the committee's proposals for it, AGM-R is the most specific fit for documentation directly preceding and setting up the AGM agenda.
2020-10-07 Swedish
Declaration of Voting Results & Voting Rights Announcements 2020
Declaration of Voting Results & Voting Rights Announcements Classification · 99% confidence The document details a change in shareholding for Linc AB in Elos Medtech AB. It explicitly uses the term 'Reason for major shareholding notification Sell' and provides 'Before the transaction' and 'After the transaction' figures, including share quantities and resulting voting rights percentages (e.g., 4.55 %, 2.04 %). This structure is characteristic of a notification regarding a significant change in ownership, which corresponds to the Major Shareholding Notification category.
2020-10-04 English
Interim / Quarterly Report 2020
Interim / Quarterly Report Classification · 100% confidence The document is a 'Delårsrapport' (Interim Report) for Q2 2020. It contains comprehensive financial statements, including income statements, cash flow analysis, key performance indicators (KPIs), and detailed management commentary on business segments (Dental, Orthopedics, Life Science) and the impact of COVID-19. It is a substantive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report. Q2 2020
2020-07-16 Swedish

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.